Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2016

01-11-2016 | Retinal Disorders

Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion

Authors: Okan Toygar, Cindy W. Mi, Daniel M. Miller, Christopher D. Riemann

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2016

Login to get access

Abstract

Purpose

To demonstrate the safety and efficacy of 27-gauge pars plana vitrectomy (PPV) in selected patients with vitreoretinal diseases requiring silicone oil (SO) tamponade.

Methods

Retrospective review of a consecutive interventional case series at a single center.

Results

Twenty-one eyes of 19 patients were included in the study. The indications for PPV and SO tamponade were as follows: fibrovascular tractional retinal detachment (12 eyes), rhegmatogenous retinal detachment with proliferative vitreoretinopathy (three eyes), primary rhegmatogenous retinal detachment (two eyes), macular hole (two eyes), vitreous hemorrhage (one eye), and endophthalmitis (one eye). All eyes underwent transconjunctival sutureless 27-gauge PPV with either 1000-cS (16 eyes) or 5000-cS (five eyes) SO tamponade. No intraoperative complications occurred. Mean preoperative best-corrected visual acuity (BCVA) was 20/300 (range, light perception to 20/40; median, counting fingers). Mean postoperative BCVA was 20/160 (range, no light perception to 20/25; median 20/300; p = 0.022). Follow-up was 6.4 ± 8.8 months (range, 1–38 months; median, 4 months). No complications relating to 27-gauge placement of SO were observed.

Conclusions

Results show that 27-gauge PPV with SO injection appears safe, is efficient, and may be considered for the surgical management of vitreoretinal diseases requiring SO tamponade.
Literature
1.
Fujii GY, De Juan E Jr, Humayun MS, Pieramici DJ, Chang TS, Awh C, Ng E, Barnes A, Wu SL, Sommerville DN (2002) A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology 109:1807–1812CrossRefPubMed
2.
Fujii GY, De Juan E Jr, Humayun MS, Chang TS, Pieramici DJ, Barnes A, Kent D (2002) Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 109:1814–1820CrossRefPubMed
3.
Lakhanpal RR, Humayun MS, de Juan E, Lim JI, Chong LP, Chang TS, Javaheri M, Fujii GY, Barnes AC, Alexandrou TJ (2005) Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 112:817–824CrossRefPubMed
4.
5.
Kadonosono K, Yamakawa T, Uchio E, Yanagi Y, Tamaki Y, Araie M (2006) Comparison of visual function after epiretinal membrane removal by 20-gauge and 25-gauge vitrectomy. Am J Ophthalmol 142:513–515CrossRefPubMed
6.
Rizzo S, Genovesi-Evert F, Murri S, Belting C, Vento A, Cresti F, Manca ML (2006) 25-gauge, sutureless vitrectomy and standart 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol 244:472–479CrossRefPubMed
7.
Fine HF, Iranmanesh R, Iturralde D, Spaide RF (2007) Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology 114:1197–1200CrossRefPubMed
8.
Siqueira RC, Gil AD, Jorge R (2007) Retinal detachment surgery with silicone oil injection in transconjunctival sutureless 23-gauge vitrectomy. Arq Bras Oftalmol 70(6):905–909CrossRefPubMed
9.
Narayanan R, Tibra N, Mathai A, Chhablani J, Kuppermann BD (2012) Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment. Retina 32(5):1013–1016CrossRefPubMed
10.
Riemann CD, Miller DM, Foster RE, Petersen MR (2007) Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion. Retina 27(3):296–303CrossRefPubMed
11.
Altan T, Acar N, Kapran Z, Unver YB, Ozdogan S (2008) Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina 28(9):1201–1206CrossRefPubMed
12.
Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC (2008) Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina 28(5):723–728CrossRefPubMed
13.
14.
Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y (2010) A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 117:93–102CrossRefPubMed
15.
Riemann CD (2011) Initial impressions with 27-gauge vitrectomy. The first generation of a new surgical modality shows promise. Retina Today Jan/Feb, pp 85–87
16.
Rizzo S, Barca F (2013) Twenty-seven-gauge sutureless microincision vitrectomy surgery: a new frontier. Retin Today 8(3):37–40
17.
Schaal S, Ozkok A, Nesmith B (2014) 27-gauge vitrectomy surgery: smaller is better. Retin Today 9(2):24–32
18.
Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC (2016) Outcomes of 27-gauge microincision vitrectomy surgery for posterior segment disease. Am J Ophthalmol 161:36–43CrossRefPubMed
19.
The Silicone Study Group (1992) Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vit- reoretinopathy: results of a randomized clinical trial. Silicone study report 1. Arch Ophthalmol 110:770–779CrossRef
20.
Abrams WG, Azen SP, McCuen BW, Flynn HW Jr, Lai MY, Ryan SJ (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone study report 11. Arch Ophthalmol 115:335–344CrossRefPubMed
21.
The Silicone Study Group (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone study report 2. Arch Ophthalmol 110:780–792CrossRef
22.
Ibarra MS, Hermel M, Prenner JL, Hassan TS (2005) Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 139(5):831–836CrossRefPubMed
23.
Oliveira LB, Reis PA (2007) Silicone oil tamponade in 23-gauge transconjunctival sutureless vitrectomy. Retina 27(8):1054–1058CrossRefPubMed
24.
Dugel PU, Zhou J, Abulon DJ, Buboltz DC (2012) Tissue attraction associated with 20-gauge, 23-gauge, and enhanced 25-gauge dual-pneumatic vitrectomy probes. Retina 32(9):1761–1766CrossRefPubMed
25.
Dugel PU, Abulon DJ, Dimalanta R (2015) Comparison of attraction capabilities associated with high-speed, dual-pneumatic vitrectomy probes. Retina 35(5):915–920CrossRefPubMed
26.
Nagpal M, Wartikar S, Nagpal K (2009) Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy. Retina 29(2):225–231CrossRefPubMed
27.
Mentens R, Stalmans P (2009) Comparison of postoperative comfort in 20 gauge versus 23 gauge pars plana vitrectomy. Bull Soc Belge Ophtalmol 311:5–10
28.
Avitabile T, Castiglione F, Bonfiglio V, Castiglione F (2010) Transconjunctival sutureless 25-gauge versus 20-gauge standard vitrectomy: correlation between corneal topography and ultrasound biomicroscopy measurements of sclerotomy sites. Cornea 29(1):19–25CrossRefPubMed
29.
Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD (2008) Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina 28(7):937–940CrossRefPubMed
30.
Woo SJ, Park KH, Hwang JM, Kim JH, Yu YS, Chung H (2009) Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy. Retina 29(4):456–463CrossRefPubMed
31.
Tan HS, Mura M, de Smet MD (2009) Iatrogenic retinal breaks in 25-gauge macular surgery. Am J Ophthalmol 148(3):427–430CrossRefPubMed
32.
Scott IU, Flynn HW Jr, Dev S, Shaikh S, Mittra RA, Arevalo JF, Kychenthal A, Acar N (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 28(1):138–142CrossRefPubMed
33.
Bamonte G, Mura M, Stevie Tan H (2011) Hypotony after 25-gauge vitrectomy. Am J Ophthalmol 151(1):156–160CrossRefPubMed
34.
35.
Gorovoy IR, Stewart JM (2013) 360° subconjunctival silicone oil after unsutured 23-gauge vitrectomy. Eye (Lond) 27(7):894–895CrossRef
36.
El-Batarny AM (2008) Transconjunctival sutureless 23-gauge vitrectomy for vitreoretinal diseases: outcome of 30 consecutive cases. Middle East Afr J Ophthalmol 15(3):99–105CrossRefPubMed
37.
Scott IU, Flynn HW Jr, Murray TG, Smiddy WE, Davis JL, Feuer WJ (2005) Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol 123(4):473–478CrossRefPubMed
38.
39.
Da Mata AP, Riemann CD, Nehemy MB, Foster RE, Petersen MR, Burk SE (2005) Indocyanine green-assisted internal limiting membrane peeling for macular holes to stain or not to stain? Retina 25(4):395–404CrossRefPubMed
Metadata
Title
Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion
Authors
Okan Toygar
Cindy W. Mi
Daniel M. Miller
Christopher D. Riemann
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3355-5

Other articles of this Issue 11/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2016 Go to the issue

Pathology

The relationship of systemic markers of renal function and vascular function with retinal blood vessel responses

Pediatrics

Four years of corneal keratoplasty in Italian paediatric patients: indications and clinical outcomes

Retinal Disorders

Pseudophakic rhegmatogenous retinal detachment: combined pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone

Basic Science

Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model

Retinal Disorders

Circadian disturbance and idiopathic central serous chorioretinopathy

Retinal Disorders

Clinical experience with eplerenone to treat chronic central serous chorioretinopathy